363 related articles for article (PubMed ID: 18565875)
1. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling.
Bailey D; O'Hare P
Biochem J; 2005 Dec; 392(Pt 2):271-81. PubMed ID: 16117725
[TBL] [Abstract][Full Text] [Related]
3. SUMO-2/3 conjugates accumulating under heat shock or MG132 treatment result largely from new protein synthesis.
Castorálová M; Březinová D; Svéda M; Lipov J; Ruml T; Knejzlík Z
Biochim Biophys Acta; 2012 Apr; 1823(4):911-9. PubMed ID: 22306003
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
[TBL] [Abstract][Full Text] [Related]
5. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
6. Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition.
Matafora V; D'Amato A; Mori S; Blasi F; Bachi A
Mol Cell Proteomics; 2009 Oct; 8(10):2243-55. PubMed ID: 19596686
[TBL] [Abstract][Full Text] [Related]
7. Identification and Characterization of SUMO-SIM Interactions.
Husnjak K; Keiten-Schmitz J; Müller S
Methods Mol Biol; 2016; 1475():79-98. PubMed ID: 27631799
[TBL] [Abstract][Full Text] [Related]
8. Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.
Cuijpers SAG; Willemstein E; Vertegaal ACO
Mol Cell Proteomics; 2017 Dec; 16(12):2281-2295. PubMed ID: 28951443
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-dependent proteolytic control of SUMO conjugates.
Uzunova K; Göttsche K; Miteva M; Weisshaar SR; Glanemann C; Schnellhardt M; Niessen M; Scheel H; Hofmann K; Johnson ES; Praefcke GJ; Dohmen RJ
J Biol Chem; 2007 Nov; 282(47):34167-75. PubMed ID: 17728242
[TBL] [Abstract][Full Text] [Related]
10. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
Eisenhardt N; Chaugule VK; Pichler A
Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
[TBL] [Abstract][Full Text] [Related]
11. RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2alpha.
van Hagen M; Overmeer RM; Abolvardi SS; Vertegaal AC
Nucleic Acids Res; 2010 Apr; 38(6):1922-31. PubMed ID: 20026589
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
13. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the tumor suppressor PTEN by SUMO.
González-Santamaría J; Campagna M; Ortega-Molina A; Marcos-Villar L; de la Cruz-Herrera CF; González D; Gallego P; Lopitz-Otsoa F; Esteban M; Rodríguez MS; Serrano M; Rivas C
Cell Death Dis; 2012 Sep; 3(9):e393. PubMed ID: 23013792
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of SUMO-dependent ubiquitylation in vitro.
Keusekotten K; Praefcke GJ
Methods Mol Biol; 2012; 832():111-23. PubMed ID: 22350879
[TBL] [Abstract][Full Text] [Related]
17. SUMO chains: polymeric signals.
Vertegaal AC
Biochem Soc Trans; 2010 Feb; 38(Pt 1):46-9. PubMed ID: 20074033
[TBL] [Abstract][Full Text] [Related]
18. Puromycin induces SUMO and ubiquitin redistribution upon proteasome inhibition.
Matsumoto H; Saitoh H
Biochem Biophys Res Commun; 2016 Jul; 476(3):153-8. PubMed ID: 27181354
[TBL] [Abstract][Full Text] [Related]
19. Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
Sriramachandran AM; Meyer-Teschendorf K; Pabst S; Ulrich HD; Gehring NH; Hofmann K; Praefcke GJK; Dohmen RJ
Nat Commun; 2019 Aug; 10(1):3678. PubMed ID: 31417085
[TBL] [Abstract][Full Text] [Related]
20. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.
Su HL; Li SS
Gene; 2002 Aug; 296(1-2):65-73. PubMed ID: 12383504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]